| A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster JFW Chan, S Yuan, KH Kok, KKW To, H Chu, J Yang, F Xing, J Liu, ... The lancet 395 (10223), 514-523, 2020 | 12232 | 2020 |
| Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study KKW To, OTY Tsang, WS Leung, AR Tam, TC Wu, DC Lung, CCY Yip, ... The Lancet infectious diseases 20 (5), 565-574, 2020 | 4073 | 2020 |
| Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan JFW Chan, KH Kok, Z Zhu, H Chu, KKW To, S Yuan, KY Yuen Emerging microbes & infections 9 (1), 221-236, 2020 | 3859 | 2020 |
| Consistent detection of 2019 novel coronavirus in saliva KKW To, OTY Tsang, CCY Yip, KH Chan, TC Wu, JMC Chan, WS Leung, ... Clinical Infectious Diseases 71 (15), 841-843, 2020 | 2525 | 2020 |
| Coronaviruses—drug discovery and therapeutic options A Zumla, JFW Chan, EI Azhar, DSC Hui, KY Yuen Nature reviews Drug discovery 15 (5), 327-347, 2016 | 2083 | 2016 |
| Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 … IFN Hung, KC Lung, EYK Tso, R Liu, TWH Chung, MY Chu, YY Ng, J Lo, ... The lancet 395 (10238), 1695-1704, 2020 | 1777 | 2020 |
| Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike L Liu, P Wang, MS Nair, J Yu, M Rapp, Q Wang, Y Luo, JFW Chan, V Sahi, ... Nature 584 (7821), 450-456, 2020 | 1507 | 2020 |
| Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 L Liu, S Iketani, Y Guo, JFW Chan, M Wang, L Liu, Y Luo, H Chu, Y Huang, ... Nature 602 (7898), 676-681, 2022 | 1309 | 2022 |
| Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in a golden Syrian hamster model: implications for disease pathogenesis and … JFW Chan, AJ Zhang, S Yuan, VKM Poon, CCS Chan, ACY Lee, ... Clinical infectious diseases 71 (9), 2428-2446, 2020 | 1287 | 2020 |
| Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-PCR assay validated in vitro and with … JFW Chan, CCY Yip, KKW To, THC Tang, SCY Wong, KH Leung, ... Journal of clinical microbiology 58 (5), 10.1128/jcm. 00310-20, 2020 | 1226 | 2020 |
| Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease JFW Chan, SKP Lau, KKW To, VCC Cheng, PCY Woo, KY Yuen Clinical microbiology reviews 28 (2), 465-522, 2015 | 1180 | 2015 |
| Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome Y Chen, W Liang, S Yang, N Wu, H Gao, J Sheng, H Yao, J Wo, Q Fang, ... The Lancet 381 (9881), 1916-1925, 2013 | 1130 | 2013 |
| The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2 VCC Cheng, SC Wong, VWM Chuang, SYC So, JHK Chen, S Sridhar, ... Journal of Infection 81 (1), 107-114, 2020 | 1061 | 2020 |
| Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory … H Chu, JFW Chan, TTT Yuen, H Shuai, S Yuan, Y Wang, B Hu, CCY Yip, ... The Lancet Microbe 1 (1), e14-e23, 2020 | 899 | 2020 |
| Animal models for COVID-19 C Muñoz-Fontela, WE Dowling, SGP Funnell, PS Gsell, AX Riveros-Balta, ... Nature 586 (7830), 509-515, 2020 | 883 | 2020 |
| Antibody evasion properties of SARS-CoV-2 Omicron sublineages S Iketani, L Liu, Y Guo, L Liu, JFW Chan, Y Huang, M Wang, Y Luo, J Yu, ... Nature 604 (7906), 553-556, 2022 | 842 | 2022 |
| Interspecies transmission and emergence of novel viruses: lessons from bats and birds JFW Chan, KKW To, H Tse, DY Jin, KY Yuen Trends in microbiology 21 (10), 544-555, 2013 | 822 | 2013 |
| Treatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset JFW Chan, Y Yao, ML Yeung, W Deng, L Bao, L Jia, F Li, C Xiao, H Gao, ... The Journal of infectious diseases 212 (12), 1904-1913, 2015 | 813 | 2015 |
| Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing L Riva, S Yuan, X Yin, L Martin-Sancho, N Matsunaga, L Pache, ... Nature 586 (7827), 113-119, 2020 | 794 | 2020 |
| Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19 H Chu, JFW Chan, Y Wang, TTT Yuen, Y Chai, Y Hou, H Shuai, D Yang, ... Clinical infectious diseases 71 (6), 1400-1409, 2020 | 769 | 2020 |
